1Kahn P. Cent gardes vaccine meeting highlights roles of antibody in protection[J]. IAVI Report,2002,6(6):1-2. 被引量：1
2Saphire E O,Paul W H,Parren I ,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1 : A Template for Vaccine Design[J]. Science, 2001, 293:1155-1159. 被引量：1
3Lynn M, Neutralizing antibody responses to HIV-1 infection[J]. IUBMB Life,2002,53:197-199. 被引量：1
4Susan Zolla-Pazner.Identifying epitope of HIV-1 that induce protective antibodies[J]. Nat Rev Immunol, 2004,4(3):199-210. 被引量：1
5Burton D R,Desrosiers R C,Doms R W, et al. HIV Vaccine design and the neutralizing antibody problem[J]. Nat Med,2004,5(3) :233-236. 被引量：1
6Cinerney TL,McLain L,Armstrong S J ,et al. A human IgG1(b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event[J]. Virol, 1997,233:313-326. 被引量：1
7Parker C E,Deterding L J, Christine Hager Braun, et al. Fine definition of the epitope on the gp41 glycoprotein of human immunodifiency virus type 1 for the neutralizing monoclonal antibody,2FS[J]. J Virol,2001,75:10906-10911. 被引量：1
8StielaG,Kunert R, Purtscher M, et al.A potent cross-clade neutralizing antibody against a novel epitope on gp41 of human immunodeficiency virus 1 [J]. AIDS Res Hum Retrovirus,2001,17:1757 -1765. 被引量：1
9Zwick M B,Labrijn A F,Meng Wang ,et al. Brodly neutralizing antibodies targeied to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41[J]. J Virol,2001,75:10892-10905. 被引量：1
10Stanfield R L,Gorny M K, Williams C, et al. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D[J]. Structure, 2004, 12:193-204. 被引量：1
二级参考文献19
1Sattentau QJ,Moulard M,Bnvet B,et al.Antibody neutralization of HIV-1 and the potential for vaccine design.Immunol Lett,1999,66(1-3): 143-149.?A 被引量：1
2Thomas Lehner.The role of CCR5 chemokine ligands and antibodies to CCR5 corecepotors in poreventing HIV infection.Trends in Immunology,2002,23(7) :347-351.?A 被引量：1
3Ruprecht RM,Ferrantelli F,Kitabwalla M,et al.Antibody protection: passive immunization of neonates against oral AIDS virus challenge.Vaccine,2003,21(24):3370-3373.?A 被引量：1
4Ferrantelli F,Ruprecht RM.Neutralizing ahtibodies against HIV-back in the major leagues? Current Opinion in Immunology,2002,14:495-502.?A 被引量：1
5Saphire EO,Parren PW,Pantophlet R,et al.Crystal structure of a neutralizing human IgG against HIV-1 :A template for vaccine design.Science,2001,293(10): 1155-1159.?A 被引量：1
6Ferrantelli F,Rasmussen RA,Hofmann-Lehmann R,et al.Do not underestimate the power of antibodies-lessons from adoptive transfer of antibodies against HIV.Vaccine,2002,20(Suppl 4A)6: 1-6.?A 被引量：1
7Chakrabarti BK,Kong W,Wu B,et al.Modifications of the human immunodefiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.J Virol,2002,76(11) :5357-5368.?A 被引量：1
8Barnett SW,Lu S,Srivastava I,et al.The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.J Virol,2001,75 (12): 5526-5540.?A 被引量：1
9Malenbaum SE,Yang D,Cheng-Mayer C.Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp 120 in humans and macaques.J Virol,2001,75(19) :9287-9296.?A 被引量：1
10Devico AL,Fouts TR,Shata MT,et al.Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1 .Vaccine,2002,20(15): 1968-1974.?A 被引量：1
